Compound EGFR Mutations and Response to EGFR Tyrosine Kinase Inhibitors

समान संसाधन

• BRIEF REPORT: Compound EGFR mutations and response to EGFR tyrosine kinase inhibitors
  द्वारा: Kobayashi, Susumu, और अन्य
  प्रकाशित: (2013)
• BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations
  द्वारा: Costa, Daniel B, और अन्य
  प्रकाशित: (2007)
• BIM Mediates EGFR Tyrosine Kinase Inhibitor-Induced Apoptosis in Lung Cancers with Oncogenic EGFR Mutations
  द्वारा: Daniel B. Costa, और अन्य
  प्रकाशित: (2007)
• Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer
  द्वारा: Norihiro Yamaguchi, और अन्य
  प्रकाशित: (2013)
• Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer
  द्वारा: Yamaguchi, Norihiro, और अन्य
  प्रकाशित: (2013)